Premium
Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib
Author(s) -
Tefferi Ayalew,
Pardanani Animesh,
Begna Kebede H.,
AlKali Aref,
Hogan William J.,
Litzow Mark R.,
Hanson Curtis A.,
Ketterling Rhett P.,
Gangat Naseema
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26714
Subject(s) - ruxolitinib , myelofibrosis , medicine , oncology , retrospective cohort study , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom